Options Rx Anti-Oxidant Oil-Free Sunscreeen — Class III drug recall D-0342-2019
Terminated recall by CBI Laboratories, Inc., reported 2018-12-26. Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
| Recall number | D-0342-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | CBI Laboratories, Inc., Fort Worth, TX, United States |
| Recall initiated | 2018-12-10 |
| Classified | 2018-12-20 |
| Reported by FDA | 2018-12-26 |
| Terminated | 2020-01-14 |
| Countries outside the US | AE, CA, NZ |
| Quantity | 2,055 tubes |
| Reason classes | potency, specification failure |
| Lot numbers | 126292, 129114, 131927, 133239 |
| Expiration dates | 2019-01, 2019-06, 2020-03 |
Product
Options Rx Anti-Oxidant Oil-Free Sunscreeen (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 oz./128 g tube, Mfg. For Credentials Skincare Fort Worth, TX 76155
Reason for recall
Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0342-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.